Novel small-molecule approach to cancer therapy could lead to new treatments
A small molecule has been developed by researchers at the Baylor College of Medicine (Houston, TX, USA) that targets the steroid receptor coactivator family of cancer cell activators, and which could lead to novel anticancer agents.
Please sign in or register for FREE
Sign in to RxNet
Not yet a member? Become a member FREE to:
- Get unlimited access to ALL CONTENT
- Read selected articles from journals such as Future Medicinal Chemistry FREE
- Receive a weekly email roundup of the latest news and expert opinions
Did you know?
Your RxNet account also gives you access to communities on regenerative medicine, real-world evidence and 3D printing in medicine. Find out more>>